Rapamycin have been shown to be effective in rodent models of autosomal dominant PKD (ADPKD), which is consistent with the findings showing that the PI3K/Akt/mTOR pathway is aberrantly activated in ADPKD [7]–[11]. Here, AKT1 is linked to autosomal dominant polycystic kidney disease.